SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 22
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 ... 19 20 21 22
|
presentations:
1 to
50 of
1074
|
Session Overview
Leah H. Rubin
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
MASH and the Progression of Cognitive Decline in Older People With HIV: A Prospective Study (ABSTRACT
453)
Katekarn Porkaew
Chulalongkorn University, Bangkok, Thailand
Metabolic Syndrome and Cognitive Impairment Among Men With and Without HIV (ABSTRACT
451)
Sara M. Hockney
Northwestern University, Chicago, IL, USA
Modifiable Factors Could Mitigate Greater Burden of Brain Small Vessel Injury in Female Individuals (ABSTRACT
448)
Elana Farrell
University of California San Francisco, San Francisco, CA, USA
The Impact of Semaglutide on Depressive Symptoms Among People With HIV (ABSTRACT
447)
Lara Haidar
University of Manitoba, Winnipeg, Canada
Discussion With Audience Questions and Answers
Session Overview
Edward Campbell
Loyola University Chicago, Chicago, IL, USA
BLM Helicase Is Required for Efficient HIV Infection in Macrophages (ABSTRACT
217)
Andrew Leal
Boston University, Boston, MA, USA
CD46 Interacts With Sp1 to Control HIV Expression in Infected T Cells (ABSTRACT
218)
Pavitra Ramdas
National Institute of Allergy and Infectious Diseases, Baltimore, MD, USA
Exploring the Role of FUBP1 in HIV Replication and Latency (ABSTRACT
216)
Fiona Carter-Tod
Northwestern University, Chicago, IL, USA
Cis- and Trans-Acting Factors That Mediate Nuclear Retention of Intron-Containing HIV-1 Transcripts (ABSTRACT
214)
Anthony Boateng
Washington University in St Louis, St Louis, MO, USA
Discussion With Audience Questions and Answers
Session Overview
Daniel R. Kuritzkes
Harvard Medical School, Boston, MA, USA
Env Mutations Are a Gateway for Acquisition of InSTI Resistance (ABSTRACT
551)
Yuta Hikichi
National Cancer Institute at Frederick, Frederick, MD, USA
Nucleocapsid Mutations During Virologic Failure of an Integrase Inhibitor-Based Regimen (ABSTRACT
585)
Charlotte Charpentier
Assistance Publique – Hôpitaux de Paris, Paris, France
Noncanonical Resistance Mutations in TLD-Treated Individuals With Unexplained Virologic Failure (ABSTRACT
553)
Nicola Coetzee
Stellenbosch University, Cape Town, South Africa
Characterization of Mutations Outside the Integrase in HIV-1 Individuals in Whom Dolutegravir Failed (ABSTRACT
550)
Aurelie Minelle Kengni Ngueko
Centre International de Référence Chantal Biya, Yaoundé, Cameroon
Discussion With Audience Questions and Answers
Session Overview
Jennifer Kates
Kaiser Family Foundation, Washington, DC, USA
Impact of US Funding Shifts on HIV Care: A Rapid Survey of Clinics and Programs in 32 Countries (ABSTRACT
1051)
Ellen Brazier
Institute for Implementation Science in Population Health, New York, NY, USA
Population-Representative Consequences of Foreign Aid Instability for HIV Services in South Africa (ABSTRACT
1054)
Lindsey Filiatreau
Washington University in St Louis, St Louis, MO, USA
Short-Term Poverty Relief and ART Adherence: Insights From a Natural Experiment of SNAP Recipients (ABSTRACT
1107)
Aaron Richterman
University of Pennsylvania, Philadelphia, PA, USA
Discussion With Audience Questions and Answers
Session Overview
Mark Sulkowski
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Simple Adiposity Measures Identify MASLD in People With HIV: Results From a US Multicenter Cohort (ABSTRACT
599)
Kara Wegermann
Duke University School of Medicine, Durham, NC, USA
Performance of Prediction Scores for Steatotic Liver Disease in Thai PWH on InSTI-Based ART (ABSTRACT
600)
Napon Hiranburana
HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
Effect of DTG/3TC vs BIC/FTC/TAF on Steatotic Liver Disease: 96-Week Analysis of PASO-DOBLE Trial (ABSTRACT
598)
Juan Macias
University of Sevilla, Sevilla, Spain
Longitudinal Associations of Semaglutide With Liver Fibrosis Score in People With HIV (ABSTRACT
601)
Jimmy Ma
University of Washington, Seattle, WA, USA
Discussion With Audience Questions and Answers
Session Overview
Ravi Goyal
University of California San Diego, La Jolla, CA, USA
Machine Learning and Longitudinal Data to Predict Unsuppressed HIV Viral Load in Rwanda, 2020-2025 (ABSTRACT
1077)
Ndinda Christian
Rwanda Biomedical Centre, Kigali, Rwanda
Effect of Machine-Learning-Guided Previsit Outreach to Patients at High Risk to Miss HIV Visits (ABSTRACT
1076)
Joseph W. Hogan
Brown University, Providence, RI, USA
Sentiment Analysis of WhatsApp Messages to Identify Unrecognized HIV Prevention Needs in Kenya (ABSTRACT
1079)
Jessica Haberer
Massachusetts General Hospital, Boston, MA, USA
Measuring Provider Quality of Care in Tanzania Using Large Language Models (ABSTRACT
1078)
Alaa Abdellatif
University of California San Francisco, San Francisco, CA, USA
Discussion With Audience Questions and Answers
Session Overview
Suzue Saito
ICAP at Columbia University, New York, NY, USA
Quantifying Uncertainty in HIV Transmission Risk From Persons With Low-Level Viremia (ABSTRACT
903)
Michael Martin
The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Network Bridges to Predict Emerging HIV Transmission Hotspots in North Carolina (ABSTRACT
890)
Ann Dennis
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Mapping Recent HIV Infections Among MSM in Thailand: Data-Driven Insights for Targeted Prevention (ABSTRACT
894)
Michael Reid
Progress Towards HIV Epidemic Control Among Young Key Populations in India (ABSTRACT
922)
Eshan U. Patel
The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Discussion With Audience Questions and Answers
Session Overview
Marina Caskey
The Rockefeller University, New York, NY, USA
Targeting the HIV-1 Latent Reservoir With Tat-CRISPR Lipid Nanoparticles (ABSTRACT
406)
Keely Gliwa
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Bispecific Biologics That Activate Latent HIV-1 Ex Vivo and In Vivo (ABSTRACT
405)
David D. Ho
Aaron Diamond AIDS Research Center, New York, NY, USA
Combination Therapy With Tat mRNA and a TLR9 Agonist Delays Post-ATI Rebound in the NHP Model (ABSTRACT
407)
Takuto Nogimori
National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan
Markedly Reduced Mutability of Networked Epitopes Promotes CTL Clearance of the Latent HIV Reservoir (ABSTRACT
408)
Fernando B. Senjobe
Harvard Medical School, Boston, MA, USA
Discussion With Audience Questions and Answers
Session Overview
Claude A. Mellins
Columbia University Irving Medical Center, New York, NY, USA
Depression, Anxiety, and Viral Suppression Among Adolescents and Young Adults in 9 African Countries (ABSTRACT
871)
Jiayu Wang
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Implementation of a Mental Health Intervention for Youth With HIV in Kenya (ABSTRACT
872)
Pamela Kohler
University of Washington, Seattle, WA, USA
|
<< first | < prev
page:
of 22
|
records per page:
next >
| last >>
|
| pages: 1 2 3 4 5 ... 19 20 21 22
|
presentations:
1 to
50 of
1074
|
